Medical Economics August 1, 2024
Richard Payerchin

The top news stories in medicine today.

Umm, high drug costs?

Rules are in place for a reason, including the Prescription Drug User Fee Amendments of 2022, which pharmaceutical makers must follow when the U.S. Food and Drug Administration reviews new drugs. The rules also cost money — $4.3 million to file for a drug using clinical data, starting Oct. 1. Here’s the official notice in the Federal Register and an analysis by Clinical Trials Arena.

‘Nonprofit in name only’

Nonprofit hospitals in fact are diversified businesses that may still benefit from tax...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Health System / Hospital, Provider, Technology
Related Articles:
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article